Table 3.
Tumor response, evaluated according to the RECIST criteria
| Tumor response according to RECIST criteria |
All cases | Pancreaticoduodenal NET | Gastrointestinal NET | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subtotal | STZ monotherapy | Combination therapy |
Subtotal | STZ monotherapy | Combination therapy | |||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| 54 | 46 | 14 | 32 | 8 | 4 | 4 | ||||||||
| CR | 2 | 4.3 | 2 | 5.3 | 1 | 11.1 | 1 | 3.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| PR | 11 | 23.9 | 9 | 23.7 | 3 | 33.3 | 6 | 20.7 | 2 | 25.0 | 1 | 25.0 | 1 | 25.0 |
| SD | 9 | 19.6 | 8 | 21.1 | 1 | 11.1 | 7 | 24.1 | 1 | 12.5 | 0 | 0.0 | 1 | 25.0 |
| PD | 25 | 54.3 | 20 | 52.6 | 5 | 55.6 | 15 | 51.7 | 5 | 62.5 | 3 | 75.0 | 2 | 50.0 |
| UK | 7 | 7 | 4 | 3 | 0 | 0 | 0 | |||||||
UK unknown